The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation
Tóm tắt
Huntington's disease (HD) is an inherited autosomal dominant neurodegenerative disorder. The most prominent sign of HD is the presence of involuntary motor movements. However, HD is also characterized by marked cognitive decline, which often precedes the onset of motor symptoms and is generally considered to be more debilitating to the patients and their families, compared to motor symptoms. Cognitive decline is widespread across most faculties of cognition in later stages of the disease, but seems to be selective in preclinical and early stages of the disease, with deficits in the HD patients' ability to multitask, their speed of processing, and executive function. It is now well established that preceding clinical diagnosis there is a preclinical stage, during which HD gene mutation carriers are relatively symptom free, despite disease pathological onset and the presence of neurodegeneration. Evidence from functional brain imaging studies suggests the presence of neural compensation in preclinical stages of HD, whereby the brain undergoes functional reorganization in response to neurodegeneration to preserve motor and cognitive performance. In this review, we will describe the underlying HD pathology with a focus on how it links to the cognitive phenotype. We will also present evidence regarding the presence of neural compensation in HD and the possible mechanisms supporting it. Finally, we will discuss current research in the field of cognitive interventions that aim to support and enhance neural compensation in HD. These research efforts could, one day, prolong the preclinical stage and assist with symptom management of those affected with HD. © 2014 International Parkinson and Movement Disorder Society
Từ khóa
Tài liệu tham khảo
Craufurd D, 2002, Huntington's Disease, 62
Craufurd D, Huntington's Disease. Manuscript in preparation
Kassubek J, 2004, Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study, J Neurol Neurosurg Psychiatry, 75, 213
Paulsen JS, 2004, fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease, Am J Neuroradiol, 25, 1715
Harris SE, 2011, The genetics of cognitive ability and cognitive ageing in healthy older people, Trends Cogn Sci, 15, 388